The Board of Directors of Acutaas Chemicals Limited is scheduled to meet on January 28, 2026, to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ending December 31, 2025. The meeting will be held at the company’s registered office and will be preceded by an Audit Committee Meeting.
Board Meeting Announcement
Acutaas Chemicals Limited has announced that a meeting of its Board of Directors will be held on Wednesday, January 28, 2026. The primary agenda of the meeting is to review and approve the company’s financial performance for the third quarter (Q3) of the fiscal year.
Financial Results on the Agenda
During the meeting, the Board will consider and approve the Unaudited Standalone & Consolidated Financial Results for the quarter and nine months ended December 31, 2025. The board’s decision on these results will be a key highlight. The meeting will take place at the company’s Registered Office.
Trading Window Closure
In compliance with insider trading regulations, the trading window for dealing in the company’s shares by designated persons has been closed since January 1, 2026. This restriction will remain in effect until 48 hours after the declaration of the financial results for the quarter and nine months ended December 31, 2025. The trading window is expected to reopen on January 31, 2026.
Source: BSE
